Read the story behind the quarter.
Income statement, balance sheet, and cash flow—connected to the customer situation, marketing choices, operating indicators, and real competitive alternatives.
Five reports to start with
Medtronic FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Medtronic reported $36.4B in revenue and $6.5B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · STESTERIS FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
STERIS reported $5.9B in revenue and $1.1B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · CRVLCorVel FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
CorVel reported $959M in revenue and $110M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · HAEHaemonetics FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Haemonetics reported $1.3B in revenue and $157M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · DOCSDoximity FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Doximity reported $645M in revenue and $215M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →121 earnings analyses
Primary sources · US GAAP · USD millions
Stryker FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Stryker reported $25.1B in revenue and $4.9B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · NBIXNeurocrine Biosciences FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Neurocrine Biosciences reported $2.9B in revenue and $619M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · DVADaVita FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
DaVita reported $13.6B in revenue and $2B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · CVSCVS Health FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
CVS Health reported $402.1B in revenue and $4.7B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · HCAHCA Healthcare FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
HCA Healthcare reported $75.6B in revenue and $6.8B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · INCYIncyte FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Incyte reported $5.1B in revenue and $1.5B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · MOHMolina Healthcare FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Molina Healthcare reported $45.4B in revenue and $781M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · MEDPMedpace Holdings FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Medpace Holdings reported $2.5B in revenue and $535M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · EXELExelixis FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Exelixis reported $2.3B in revenue and $872M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ELVElevance Health FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Elevance Health reported $199.1B in revenue and $5.7B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · BIIBBiogen FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Biogen reported $9.9B in revenue and $1.3B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · MTDMettler-Toledo FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Mettler-Toledo reported $4B in revenue and $869M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · REGNRegeneron Pharmaceuticals FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Regeneron Pharmaceuticals reported $14.3B in revenue and $3.6B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · GEHCGE HealthCare Technologies FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
GE HealthCare Technologies reported $20.6B in revenue and $2.8B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ENSGThe Ensign Group FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
The Ensign Group reported $5B in revenue and $425M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ISRGIntuitive Surgical FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Intuitive Surgical reported $10.1B in revenue and $2.9B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · AAgilent Technologies FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Agilent Technologies reported $6.9B in revenue and $1.5B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · COOThe Cooper Companies FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
The Cooper Companies reported $4.1B in revenue and $683M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · SLPSimulations Plus FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Simulations Plus reported $79M in revenue and -$71M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · CORCencora FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Cencora reported $321.3B in revenue and $2.6B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · BDXBecton Dickinson FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Becton Dickinson reported $21.8B in revenue and $2.6B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · TECHBio-Techne FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Bio-Techne reported $1.2B in revenue and $102M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · CAHCardinal Health FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Cardinal Health reported $222.6B in revenue and $2.3B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · RMDResMed FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
ResMed reported $5.1B in revenue and $1.7B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →
